Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Dil
-
AutoZone to Release Third Quarter Fiscal 2025 Earnings May 27, 2025
-
Finning to report Q1 2025 results on May 12 and hold investor call on May 13, 2025
-
Report on Financial Results for the Year Ended December 31, 2024
-
ARCPOINT REPORTS 2024 YEAR END FINANCIAL RESULTS AND ANNOUNCES MANAGEMENT CHANGE
-
Canacol Energy Ltd. To Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025; Hold Conference Call on Friday, May 9, 2025
-
ROHM's Latest 2kV SiC MOSFETs Integrated into Semikron Danfoss' Module for SMA's Large-Scale Power Conversion System
-
ROHM's Latest 2kV SiC MOSFETs Integrated into Semikron Danfoss' Module for SMA's Large-Scale Power Conversion System
-
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
-
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
-
Storytime Bookshop Launches $15,000 Crowdfunding Campaign to Expand Access to Books and Creative Literacy Programs
-
Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
-
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
-
Blade Air Mobility Announces Date for First Quarter Ending March 31, 2025 Earnings Release Conference Call
-
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
-
RBB Bancorp Reports First Quarter 2025 Earnings
-
Trident Filed 2024 Annual Report on Form 20-F
-
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
-
Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow
-
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
-
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
-
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
-
SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024
-
Phoenix Asia Holdings Limited Announces Closing of Its Initial Public Offering
-
Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
-
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
-
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer
-
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
-
iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates
-
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
-
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025
-
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
-
Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting
-
Portillo’s Announces Plan to Further Strengthen Board Through Cooperation Agreement with Engaged Capital
-
Gladius Global Advisors Announces Manny Abin as CEO, Bringing Asset Management Expertise and Innovation to the Table
-
Ebang International Reports Financial Results for Fiscal Year 2024
-
Cohen & Company Sets Release Date for First Quarter 2025 Financial Results
-
Transocean Ltd. Reports First Quarter 2025 Results
-
Cohen & Company Sets Release Date for First Quarter 2025 Financial Results
-
Powell Max Limited Announces 2024 Audited Financial Results
-
Two Senior Executives Join the Diginex Team to Drive Sustainable Finance Initiatives and strategic M&A
-
SPAR Group, Inc. Receives Nasdaq Notice of Late Filing of its Form 10-K
-
Two Senior Executives Join the Diginex Team to Drive Sustainable Finance Initiatives and strategic M&A
-
Turtle Beach Corporation to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
-
Piedmont Office Realty Trust, Inc. Releases First Quarter 2025 Results
-
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

